ATGE vs LOPE

ATGE's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score prevents a full distress risk assessment. The company demonstrates strong profitability and growth, with robust earnings surprises and high ROE, but faces headwinds from a bearish technical trend and weak liquidity ratios. Valuation is mixed: trading below analyst target of $158.25 but above the conservative Graham Number of $76.73, reflecting premium pricing for growth. Despite solid fundamentals and sector outperformance in ROE and margins, the lack of insider activity and near-term technical weakness temper bullishness.

LOPE presents a dichotomy between stellar fundamental profitability and bearish market sentiment. The Piotroski F-Score of 4/9 indicates stable but not strong financial health, though this is offset by an exceptionally low Debt/Equity ratio (0.14) and high liquidity. While the stock trades significantly above its Graham Number ($69.99), it remains slightly below its growth-based intrinsic value ($175.4). Strong ROE (28.24%) and a consistent 25-quarter track record of earnings beats are countered by a 0/100 technical trend and bearish insider sentiment.